The Leader in Cost Effectiveness Analytics, Change Management,
and Chronic Care Management for Hospitals

Value-based medicine depends on Cost Effectiveness and Change Management.

Knowing the total “episode of care” cost of one medical device, pharmaceutical, or technology vs. its key competitors is one of the most critical data challenges facing hospitals and health care today. But data in the absence of hands-on change management does not accomplish anything. That’s why CAVA delivers BOTH data analytics and physician / provider program support to all of our hospital clients focused on the delivery of value-based care.

Chronic Care Management

And beginning in 2017, CAVA also offers powerful Chronic Care Management programs that not only significantly improve the care of our client hospitals’ chronically ill Medicare patients, but also generates very significant additional revenues.

Online Cost Effectiveness Platform

CAVA’s online CAVAlytics® Cost Effectiveness analytics — which determine the total cost of a product or health care intervention compared to one or more alternatives — enables:

  • Hospitals and IDNs to lower costs and make fiscally sound product purchasing and clinical usage decisions; and
  • Device and Pharmaceutical manufacturers to demonstrate their products’ total episode-of-care value proposition to key hospital purchasers, economic buyers, and clinical decision makers

CAVA is the Healthcare IT leader in online cost effectiveness analytics and services. We help our Hospital / IDN, Device, and Pharmaceutical industry clients leverage analytics for their most demanding economic and clinical purchasing, usage, commercialization, and coverage challenges.

Please contact our leadership team today for a 30-minute live demonstration of our Cost Effectiveness and Chronic Care Management solutions.

Hospitals / IDNs

Customized online CCE analytics that demonstrate total episode-of-care costs in side-by-side product comparisons using our proprietary, interactive platform.

Learn More
Is it possible to divide Cialis 20 mg The active substance of the drug begins to "work" at the moment a man feels natural arousal. It is important to emphasize that tablets do not directly affect the degree of arousal, their action is aimed at achieving the highest degree of potency.

Medical Device Industry

CE analytics and predictive modeling solutions that allow medical-surgical clients to proactively and transparently demonstrate the comparative value of their technology.

Learn More

Chronic Care Management

CAVA’s Chronic Care Management program with industry leader CircleLink Health delivers best practice clinical care, according to strict CMS guidelines, while generating additional 6- and 7-figure annual revenue to hospitals.

Learn More

Cava Robotics

CAVA Robotics offers hospitals proprietary, industry-leading predictive analytics to assess the economic, clinical, and operational cost-effectiveness of its da Vinci robotics program.

Learn More

Notable media features

Featured speaking engagements

The latest CAVA news

Nutrition Risk Assessment Saves $4.8M, Cuts Hospital Readmissions

Conducting nutrition risk assessments in the inpatient setting can significantly reduce hospital readmissions and shorten length of stay.
Click here for more.

CAVA CEO Josh Feldstein Investigator and Co-Author of Journal of Parenteral and Enteral Nutrition Publication December 2016

JPEN has published "Budget Impact of a Comprehensive Nutrition-focused Quality Improvement Program for Malnourished Hospitalized Patients” in its December 2016 edition.

The James R. & Helen D. Russell Institute for Research & Innovation are proud to welcome…Josh Feldstein, President / CEO of the Center for Applied Value Analysis (CAVA), as our keynote speaker at 2015 Advocate Research & Innovation Forum on Wed Oct 28th.

Click here for details.